Alphalan Melphalan Tablets IP 2mg

  • Product Name : Alphalan Melphalan Tablets IP 2mg
  • Category : Tablet
  • Manufacturer Name :
  • Trade Name : Alphalan
  • Available Dosage : 2mg
  • Packing : Bottle
  • Pack Insert/Leaflet : 1 Bottle/25 Tablets
  • Ingredients :
  • Formulation : Tablet
  • Therapeutic use : To treat multiple myeloma and ovarian cancer
  • Production Capacity : 100000

Introduction to Alphalan Melphalan Tablets IP 2mg:

Alphalan Melphalan Tablets IP 2mg are a specialized chemotherapy medication designed to treat certain types of cancer, including multiple myeloma and ovarian cancer. Each tablet contains 2mg of Melphalan, an alkylating agent that works by interfering with the growth and spread of cancer cells in the body.


Uses of Alphalan Melphalan Tablets IP 2mg:

Multiple Myeloma Treatment: Effective in managing and treating multiple myeloma, a type of cancer that affects plasma cells in the bone marrow.

Ovarian Cancer Treatment: Used in the treatment of ovarian cancer, helping to slow the growth and spread of cancer cells.

Palliative Care: Provides relief from cancer symptoms and improves quality of life in advanced cancer cases.


Benefits of Alphalan Melphalan Tablets IP 2mg:

Potent Chemotherapy Agent: Contains Melphalan, a powerful alkylating agent known for its efficacy in cancer treatment.

Targeted Action: Specifically designed to interfere with the DNA replication of cancer cells, thereby slowing their growth and spread.

Improved Quality of Life: Helps manage cancer symptoms and enhances the quality of life for patients undergoing treatment.

Convenient Dosage Form: Available in tablet form for ease of administration and patient compliance.


Mechanism of Alphalan Melphalan Tablets IP 2mg:

Alkylating Agent: Melphalan works by adding alkyl groups to the DNA of cancer cells, causing cross-linking and breaking of DNA strands. This action prevents cancer cells from dividing and growing, leading to their eventual death.

Targeted DNA Damage: The targeted damage to cancer cell DNA results in reduced tumor growth and progression, aiding in cancer management.